Form 4: HOOKIPA Pharma Director Acquires Stock Options
SEC Form 4 Filing
Mary Theresa Coelho, a director of HOOKIPA Pharma Inc., acquired 49,000 stock options on June 17, 2024.
Summary
- On June 17, 2024, Mary Theresa Coelho, a director at HOOKIPA Pharma Inc., acquired 49,000 stock options.
- The exercise price of these options is $0.71.
- The options vest on the earlier of June 17, 2025, or the date of the Issuer's next annual meeting of its stockholders.
- The options expire on June 17, 2034.
- Following the transaction, Ms. Coelho directly owns 49,000 derivative securities.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing regarding stock option grants, indicating a neutral sentiment.
Industry Context
This is a standard SEC Form 4 filing, reflecting a change in beneficial ownership of securities. It is common for directors and officers of publicly traded companies to receive stock options as part of their compensation.
Stakeholder Impact
- The acquisition of stock options by a director may have a minor positive impact on shareholder sentiment, as it aligns the director's interests with those of the shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of transaction: Mary Theresa Coelho acquired 49,000 stock options. |
| 06/17/2025 | Earliest vesting date for the stock options. |
| 06/17/2034 | Expiration date for the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.